- Issuer ticker
-
SAVA
- Reported as of
-
23 May 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
16 Jul 2025, 16:04:20 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Eric J. Schoen by Power of Attorney
Key filing fact
Patrick J. MD Scannon PhD filed Form 4 for CASSAVA SCIENCES INC (SAVA) on 16 Jul 2025.
Key facts
- This page summarizes Patrick J. MD Scannon PhD's Form 4 filing for CASSAVA SCIENCES INC (SAVA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Jul 2025, 16:04.
Change
- Previous filing in this sequence was filed on 13 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001222790
Primary reporting owner
SCANNON PATRICK J MD PHD
- Relationship
-
Director
- Address
- 6801 N CAPITAL OF TEXAS HWY, BLDG 1, SUITE 300, AUSTIN
- Signature
- /s/ Eric J. Schoen by Power of Attorney
- Signature date
- 16 Jul 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SAVA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +26,500
- Change %
- Price
-
$0.000000
- Shares after
- 26,500
- Date
- 23 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,500
- Exercise price
- $2.11
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote